Literature DB >> 12893765

T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells.

Ruth Lyck1, Yvonne Reiss, Nicole Gerwin, John Greenwood, Peter Adamson, Britta Engelhardt.   

Abstract

Endothelial intercellular adhesion molecule 1 (ICAM-1) and ICAM-2 are both involved in lymphocyte extravasation during immunosurveillance and inflammation. To define their exact role during T-cell extravasation, we used mouse T cells and ICAM-1-/-ICAM-2-/- brain endothelioma cells. ICAM-1-/-ICAM-2-/- brain endothelioma cells did not support transendothelial migration (TEM) of T cells in vitro. Re-expression of different ICAM-1 mutants in the ICAM-1-/-ICAM-2-/- endothelioma line bEndI1/2.1 or in the ICAM-1-/- endothelioma line bEndI1.1 demonstrated that the extracellular domain of ICAM-1 suffices to support T-cell adhesion while the presence of the cytoplasmic tail was strictly required for TEM. Surprisingly, tyrosine phosphorylation of endothelial ICAM-1 was not necessary for TEM of T cells or for Rho guanosine triphosphatase (RhoGTPase) activation. Furthermore, cytoplasmic deletion mutants of ICAM-1 were unable to mediate RhoGTPase activation. Thus, our data demonstrate that the cytoplasmic tail of endothelial ICAM-1-independently from tyrosine phosphorylation-is essential for supporting TEM of T lymphocytes, while Rho signaling is involved in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893765     DOI: 10.1182/blood-2003-02-0358

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Authors:  Oliver Steiner; Caroline Coisne; Britta Engelhardt; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

Review 2.  Rho GTPases and leucocyte-induced endothelial remodelling.

Authors:  Jaime Millán; Anne J Ridley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 3.  Molecular mechanisms involved in T cell migration across the blood-brain barrier.

Authors:  B Engelhardt
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

Review 4.  Endothelial membrane reorganization during leukocyte extravasation.

Authors:  Natalia Reglero-Real; Beatriz Marcos-Ramiro; Jaime Millán
Journal:  Cell Mol Life Sci       Date:  2012-05-10       Impact factor: 9.261

5.  ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.

Authors:  Lin Yang; Richard M Froio; Tracey E Sciuto; Ann M Dvorak; Ronen Alon; Francis W Luscinskas
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

Review 6.  The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.

Authors:  Britta Engelhardt; Lydia Sorokin
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 7.  Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration.

Authors:  Arshad Rahman; Fabeha Fazal
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

8.  The RhoA guanine nucleotide exchange factor, LARG, mediates ICAM-1-dependent mechanotransduction in endothelial cells to stimulate transendothelial migration.

Authors:  Elizabeth C Lessey-Morillon; Lukas D Osborne; Elizabeth Monaghan-Benson; Christophe Guilluy; E Timothy O'Brien; Richard Superfine; Keith Burridge
Journal:  J Immunol       Date:  2014-02-28       Impact factor: 5.422

9.  ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration.

Authors:  Roberta Martinelli; Matthew Gegg; Rebecca Longbottom; Peter Adamson; Patric Turowski; John Greenwood
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

Review 10.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.